Pentixapharm Holding AG Sustainability Reports

Pentixapharm Holding AG is a clinical-stage biopharmaceutical company focusing on the development of radiopharmaceuticals for therapeutic and diagnostic use.

Sector: Manufacturing

Country: Germany

Exchange: Börse Frankfurt

LEI: 3912005VBOVXNDXEQZ36

FIGI: BBG01Q0BTLL5

15 reports from 2021 to 2025

• Pentixapharm Holding AG 2025 Annual Report
• Pentixapharm Holding AG 2025 Declaration on Corporate Governance and Corporate Governance Report
• Pentixapharm Holding AG 2024 Annual Report
• Pentixapharm Holding AG 2024 Annual Report
• Pentixapharm Holding AG 2023 Audit Report on Annual Financial Statements